MAPT and Alzheimer disease: We extended these analyses, using Elecsys data for Tau and Aβ1-42, and found that in MCI and AD subjects with low CSF Aβ1-42, NPTX2 was a significant predictor of atrophy rates, whereas Nfl was not (data not shown).